Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Ototoxicity 1Hemangioma, Cavernous, Central Nervous System 1Advanced Renal Cell Carcinoma (RCC) 1

Interventions

Hydroxymethylglutaryl-CoA Reductase Inhibitors 1Atorvastatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Ototoxicity × Atorvastatin × Clear all
NCT06553157 2026-01-20

Statins Effect on Incidence of Side Effects of Platinum Based Chemotherapy

Minia University

Phase 1/2 Completed
56 enrolled

Ototoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡